RTP Mobile Logo

1st-line Tx 60 yo w/ unresectable mets 1 y after adj FOLFOX? Pt age at which you don’t want to use bev?

1st-line Tx 60 yo w/ unresectable mets 1 y after adj FOLFOX? Pt age at which you don’t want to use bev?

What is your usual recommendation for first-line therapy for a 60-year-old patient who presents with widespread, unresectable metastases (PS = 0) 12 months after completion of adjuvant FOLFOX for Stage III KRAS wild-type (wt) colon cancer?

The patient had fared well on adjuvant FOLFOX except for minimal peripheral neuropathy that resolved in 6 months.

COCCRC13/1

TARGET AUDIENCE
This activity is intended for medical oncologists, hematologist-oncologists, hematology-oncology fellows, oncology nurses, radiation oncologists, colorectal-general surgeons and other healthcare practitioners involved in the management of colorectal cancer.

OVERVIEW OF ACTIVITY

Consensus or Controversy, Issue 1: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Colorectal Cancer in the Adjuvant Setting

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013

iJournal Club - Lung Cancer: 2013